Abstract
Background One-carbon metabolism (OCM), a biochemical pathway dependent on micronutrients including folate and vitamin B12, plays an essential role in aging-related physiological processes. DNA methylation-based aging biomarkers may be influenced by OCM.
Objective This study investigated associations of OCM-related biomarkers with epigenetic aging biomarkers in the National Health and Nutrition Examination Survey (NHANES).
Methods Blood DNA methylation was measured in adults aged ≥50 years in the 1999-2000 and 2001-2002 cycles of NHANES. The following epigenetic aging biomarkers were included: Horvath1, Horvath2, Hannum, PhenoAge, GrimAge2, DunedinPoAm, and DNA methylation telomere length (DNAmTL). We tested for associations of serum folate, red blood cell (RBC) folate, vitamin B12, homocysteine, and methylmalonic acid concentrations with epigenetic age deviation (EAD) among 2,346 participants with epigenetic and nutritional status biomarkers using survey weighted general linear regression models adjusting for sociodemographics, BMI, and behavioral factors.
Results A doubling of serum folate concentration was associated with −0.82 years (95% confidence interval (CI) = −1.40, −0.23) lower GrimAge EAD, −0.13 SDs (−0.22, −0.03) lower DunedinPoAm, and 0.02 kb (0.00, 0.04) greater DNAmTL EAD. Associations were attenuated after adjusting for smoking status and alcohol intake, folate antagonists. Conversely, a doubling in homocysteine concentration was associated with 1.05 years (0.06, 2.04) greater PhenoAge EAD, 1.93 years (1.16, 2.71) greater GrimAge2 EAD, and 0.26 SDs (0.10, 0.41) greater DunedinPoAm. Associations with GrimAge2 EAD and DunedinPoAm were robust to alcohol and smoking adjustment.
Conclusions In a nationally representative sample of U.S. adults, greater folate, a carbon donor, was associated with lower EAD, and greater homocysteine, an indicator of OCM deficiencies, was associated with greater EAD; however, some associations were influenced by smoking status. Future research should focus on high-risk populations. Randomized controlled trials with long-term follow-up are also needed to established causality and investigate the clinical relevance of changes in EAD.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
AKB is supported by the National Institutes of Health (NIH) grant K99ES035109. JNE and AC are supported by the NIH grant R01ES031259. This research was also supported by the National Institute on Minority Health and Health Disparities (R01MD011721, MPI: BLN and DHR; and R01MD016595). The funders had no role in the decision to publish, preparation, review, or approval of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All datasets used in the current study are publicly available from the NHANES website.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Sources of support: AKB is supported by the National Institutes of Health (NIH) grant K99ES035109. JNE and AC are supported by the NIH grant R01ES031259. This research was also supported by the National Institute on Minority Health and Health Disparities (R01MD011721, MPI: BLN and DHR; and R01MD016595). The funders had no role in the decision to publish, preparation, review, or approval of the manuscript.
Data Availability
All datasets analyzed in the current study are publicly available from the NHANES website.
Abbreviations
- ADM
- adrenomedullin
- B2M
- β-2 microglobulin
- BKMR
- Bayesian Kernel Machine Regression
- BMI
- body mass index
- BMIQ
- beta mixture quantile
- CI
- confidence interval
- CpG
- cytosine-guanine dinucleotide
- CRP
- C-reactive protein
- CVD
- cardiovascular disease
- DNAmTL
- DNA methylation telomere length
- DunedinPoAm
- Dunedin Pace-of-Aging
- EAD
- epigenetic age deviation
- Hcy
- homocysteine
- HHS
- Department of Health and Human Services
- GDF-15
- growth differentiation factor 15
- MAE
- median absolute error
- MMA
- methylmalonic acid
- NCHS
- National Center for Health Statistics
- NHANES
- National Health and Nutrition Examination Survey
- OCM
- one-carbon metabolism
- PAI-1
- plasminogen activation inhibitor 1
- PIR
- poverty to family income ratio
- QC
- quality control
- RBC
- red blood cell
- SAH
- S-adenosylhomocysteine
- SAM
- S-adenosylmethionine
- SD
- standard deviation
- TIMP-1
- tissue inhibitor metalloproteinase 1
- US
- United States